Science
Mechanism of Action
Activates the Nrf2 antioxidant pathway while simultaneously inhibiting cyclooxygenase-2 (COX-2) and NF-κB/MAPK inflammatory cascades. Additionally suppresses tyrosinase enzyme activity to reduce melanogenesis and provide skin brightening effects.
Research
Clinical Evidence
Medium confidence0.005%
Key findings
- 01 Human dermal fibroblast study at 10-100 μg/mL showed dose-dependent antioxidant activity with cytotoxicity above 100 μg/mL
- 02 Related compound study demonstrated 24% dermal absorption at 0.7% concentration in o/w cream formulation
Transparency
Dusting Analysis
Often included at trace amounts primarily for fragrance masking rather than therapeutic benefit, with regulatory limits restricting meaningful active concentrations
The Formula
Formulation
Stability
Extremely unstable in aqueous environments due to hydrolysis into ketoacids. Requires oil-based systems, nanoemulsions, or cyclodextrin encapsulation for stability.
Synergies
- cyclodextrins
- oil-soluble antioxidants
- nanoemulsion systems
Conflicts
- nitrosating agents
- strong oxidizing agents
- unprotected aqueous formulations
Safety
Safety Profile
Limited to 0.01% in some regions as fragrance component. GRAS status for food use but lacks comprehensive topical safety assessment.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Promising bioactivity is severely limited by formulation instability and restrictive concentration limits that prevent therapeutic efficacy.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources